Literature DB >> 18974146

Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells.

Leah A Damiani1, Christin M Yingling, Shuguang Leng, Paul E Romo, Jun Nakamura, Steven A Belinsky.   

Abstract

A better understanding of key molecular changes during transformation of lung epithelial cells could affect strategies to reduce mortality from lung cancer. This study uses an in vitro model to identify key molecular changes that drive cell transformation and the likely clonal outgrowth of preneoplastic lung epithelial cells that occurs in the chronic smoker. Here, we show differences in transformation efficiency associated with DNA repair capacity for two hTERT/cyclin-dependent kinase 4, immortalized bronchial epithelial cell lines after low-dose treatment with the carcinogens methylnitrosourea, benzo(a)pyrene-diolepoxide 1, or both for 12 weeks. Levels of cytosine-DNA methyltransferase 1 (DNMT1) protein increased significantly during carcinogen exposure and were associated with the detection of promoter hypermethylation of 5 to 10 genes in each transformed cell line. Multiple members of the cadherin gene family were commonly methylated during transformation. Stable knockdown of DNMT1 reversed transformation and gene silencing. Moreover, stable knockdown of DNMT1 protein before carcinogen treatment prevented transformation and methylation of cadherin genes. These studies provide a mechanistic link between increased DNMT1 protein, de novo methylation of tumor suppressor genes, and reduced DNA repair capacity that together seem causal for transformation of lung epithelial cells. This finding supports the development of demethylation strategies for primary prevention of lung cancer in smokers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974146     DOI: 10.1158/0008-5472.CAN-08-1276

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

Review 1.  Double-strand breaks and the concept of short- and long-term epigenetic memory.

Authors:  Christian Orlowski; Li-Jeen Mah; Raja S Vasireddy; Assam El-Osta; Tom C Karagiannis
Journal:  Chromosoma       Date:  2010-12-21       Impact factor: 4.316

Review 2.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

3.  Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model.

Authors:  Steven A Belinsky; Marcie J Grimes; Maria A Picchi; Hugh D Mitchell; Chris A Stidley; Yohannes Tesfaigzi; Meghan M Channell; Yanbin Liu; Robert A Casero; Stephen B Baylin; Mathew D Reed; Carmen S Tellez; Thomas H March
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

4.  Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza.

Authors:  Ilona Jaspers; Katherine M Horvath; Wenli Zhang; Luisa E Brighton; Johnny L Carson; Terry L Noah
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-30       Impact factor: 6.914

5.  First generation stochastic gene episilencing (step1) model and applications to in vitro carcinogen exposure.

Authors:  Bobby R Scott
Journal:  Dose Response       Date:  2011-08-26       Impact factor: 2.658

Review 6.  Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications.

Authors:  Yi Cao
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

7.  DNA-PKc deficiency drives pre-malignant transformation by reducing DNA repair capacity in concert with reprogramming the epigenome in human bronchial epithelial cells.

Authors:  Ivo Teneng; Maria A Picchi; Shuguang Leng; Christopher P Dagucon; Suresh Ramalingam; Carmen S Tellez; Steven A Belinsky
Journal:  DNA Repair (Amst)       Date:  2019-04-27

8.  RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation.

Authors:  Bo-Kuan Wu; Szu-Chieh Mei; Charles Brenner
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer.

Authors:  Mathewos Tessema; Christin M Yingling; Amanda M Snider; Kieu Do; Daniel E Juri; Maria A Picchi; Xiequn Zhang; Yushi Liu; Shuguang Leng; Carmen S Tellez; Steven A Belinsky
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

10.  Investigating the epigenetic effects of a prototype smoke-derived carcinogen in human cells.

Authors:  Stella Tommasi; Sang-in Kim; Xueyan Zhong; Xiwei Wu; Gerd P Pfeifer; Ahmad Besaratinia
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.